Sana Biotechnology

SANANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$979.586 M

$3.52 +3.23%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$244.2M

Loss-making

Shares outstanding

278,291,590

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#50Odyssey TherapeuticsODTX$1.02B
#51Replimune GroupREPL$1.01B
#52Sana BiotechnologySANA$979.6M
#53Attovia TherapeuticsATTO$919.3M
#54Aura BiosciencesAURA$826.5M

Where these numbers come from

Share counts and financials for Sana Biotechnology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.